| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/26/2002 | US20020197657 Apoptosis-related compounds and their use |
| 12/26/2002 | US20020197626 Protein-protein interactions |
| 12/26/2002 | US20020197615 Nucleotide sequences coding polypeptide for use as diagnostic tool |
| 12/26/2002 | US20020197612 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
| 12/26/2002 | US20020197288 Topical applying; mixture of fibers and ubiquinone |
| 12/26/2002 | US20020197284 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 12/26/2002 | US20020197279 Methods for treating tension headache |
| 12/26/2002 | US20020197278 Covalent coupling of botulinum toxin with polyethylene glycol |
| 12/26/2002 | US20020197277 Cell culture system for synthesis of infectious hepatitis C virus |
| 12/26/2002 | US20020197267 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 12/26/2002 | US20020197265 Methods and compounds for the treatment of immunologically - mediated diseases of the respiratory system using mycobacterium vaccae |
| 12/26/2002 | US20020197263 Novel compounds |
| 12/26/2002 | US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
| 12/26/2002 | US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 12/26/2002 | US20020197254 Soluble lymphotoxin beta receptor and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for treatment |
| 12/26/2002 | US20020197248 Method for treating a LFA-1-mediated disorder |
| 12/26/2002 | US20020197246 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 12/26/2002 | US20020197245 Antitumour compositions containing taxane derivatives |
| 12/26/2002 | US20020197244 Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 12/26/2002 | US20020197242 Composition for filling bone defects |
| 12/26/2002 | US20020197235 Method for short-term and long-term drug dosimetry |
| 12/26/2002 | US20020197234 Immunologic activities of rhesus cytomegalovirus encoded IL-10 and human cytomegalovirus encoded IL-10 |
| 12/26/2002 | US20020197233 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 12/26/2002 | US20020197232 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 12/26/2002 | US20020196522 Compliant mechanism and method of forming same |
| 12/26/2002 | US20020195452 Stackable low depth tray |
| 12/26/2002 | US20020195100 Vaporizing device for administering sterile medication |
| 12/26/2002 | CA2391588A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one anti-inflammatory compound |
| 12/26/2002 | CA2391585A1 Cosmetic or dermatological composition including an association between a compound of the n-acylamino amides family and at least one matrix metalloproteinase inhibitor |
| 12/26/2002 | CA2391580A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one antifungal agent or at least one antibacterial agent |
| 12/26/2002 | CA2391574A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one muscle relaxant agent |
| 12/26/2002 | CA2391568A1 Collapsin response mediator protein-1 |
| 12/25/2002 | CN1387578A Novel compound F-15078 |
| 12/25/2002 | CN1387577A Process for producing product contg. antihypertensive tripeptides |
| 12/25/2002 | CN1387576A Sequence-specific DNA recombination in ekaryotic cells |
| 12/25/2002 | CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 12/25/2002 | CN1387571A Mammalian cytokines, related reagents and methods |
| 12/25/2002 | CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity |
| 12/25/2002 | CN1387569A Apoptin-associating protein |
| 12/25/2002 | CN1387568A Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 12/25/2002 | CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 12/25/2002 | CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 12/25/2002 | CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 12/25/2002 | CN1387535A Novel muskelin and its application and producing method |
| 12/25/2002 | CN1387503A Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders |
| 12/25/2002 | CN1387441A Use of nitric oxide for treatment of airway constriction |
| 12/25/2002 | CN1387440A Methods for treating diabetes |
| 12/25/2002 | CN1386862A Process for preparing cicer protein polypeptide by enzyme method and its use |
| 12/25/2002 | CN1386856A Polypeptide-aconitase-8.8 and polynucleotide for coding it |
| 12/25/2002 | CN1386855A Polypeptide-zinc metal endonuclease-41.25 and polynucleotide for coding it |
| 12/25/2002 | CN1386853A Polypeptide-fatty acid enzyme-8.91 and polynucleotide for coding it |
| 12/25/2002 | CN1386852A Polypeptide-pyrophosphatase-8.91 and polynucleotide for coding it |
| 12/25/2002 | CN1386851A Polypeptide-human alcohol dehydrogenase III-51.37 and polynucleotide for coding it |
| 12/25/2002 | CN1386850A Polypeptide-glyceraldehyde-3-phosphate dehydrogenase-8.91 and polyncleotide for coding it |
| 12/25/2002 | CN1386754A Non-T cell conjugating peptide and its use |
| 12/25/2002 | CN1386750A Process for preparing platelet factor 4 as genetically engineered medicine |
| 12/25/2002 | CN1386547A High-solidifiability fibrinogen gelatin |
| 12/25/2002 | CN1097213C Luminous hand of electroluminescence |
| 12/25/2002 | CN1097058C Platelet growth accelerator |
| 12/25/2002 | CN1096869C Sustained release formulation of animal growth hormone and process for preparation thereof |
| 12/25/2002 | CN1096859C Xanthine deriv. |
| 12/25/2002 | CN1096855C Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof |
| 12/24/2002 | US6498644 Alignment system of wafer stage |
| 12/24/2002 | US6498244 Adeno-associated virus capsid immunologic determinants |
| 12/24/2002 | US6498243 Epimorphin antagonist and process for producing it |
| 12/24/2002 | US6498238 Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| 12/24/2002 | US6498237 Induction of endhotelial procoagulant is inhibited and induction of fibrin deposition is enhanced; cytotoxicity and receptor binding activities unaffected; monoclonal antibody |
| 12/24/2002 | US6498234 Compounds |
| 12/24/2002 | US6498233 Nucleic acid transfer system |
| 12/24/2002 | US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy |
| 12/24/2002 | US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors |
| 12/24/2002 | US6498147 Suppression of nuclear factor-κb dependent processes using oligonucleotides |
| 12/24/2002 | US6498144 Enhancing wound healing and organ transplantation |
| 12/24/2002 | US6498143 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 12/24/2002 | US6498142 Osteogenic protein-1 (op-1) and other members of the op-1 subfamily of the tgf-.beta. superfamily of growth factors |
| 12/24/2002 | US6498141 Method and apparatus for preparing an acellular red blood cell substitute |
| 12/24/2002 | US6498140 Use of isolated domains of type IV collagen to modify cell and tissue interactions |
| 12/24/2002 | US6498139 Remedies for diseases caused by insulin resistance |
| 12/24/2002 | US6498035 Antisense modulation of MEKK3 expression |
| 12/24/2002 | US6498021 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-8 and uses thereof |
| 12/24/2002 | US6498019 Lecithin-cholesterol acyltransferase protein |
| 12/24/2002 | US6498015 Genetic engineering; production of macrophage derived chemokine; drug screening for antiinflammatory agents |
| 12/24/2002 | US6498014 Detecting peta-3 antigen for cancer diagnosis |
| 12/24/2002 | US6498008 Method for detecting swine infertility and respiratory virus |
| 12/24/2002 | US6498006 Administering mixture of liposome and drug |
| 12/24/2002 | US6497906 Anticholesterol, reduced menstrual bleeding |
| 12/24/2002 | US6497887 Delivery system for topical application to skin comprising freeze-dried, partially crosslinked polymeric gel membrane containing hyaluronic acid as disrupting agent, which can be returned to dissolvable gel upon application of wetting agent |
| 12/24/2002 | US6497884 Viable chimeric recombinant flavivirus comprising region of nucleic acid encoding premembrane and envelope structural proteins of langat virus linked to region of nucleic acid encoding non-structural proteins of dengue type 4 virus |
| 12/24/2002 | US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell |
| 12/24/2002 | US6497880 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus |
| 12/24/2002 | US6497878 Systemically administering amount of anti-interleukin-8 antibody effective to treat cerebral infarction |
| 12/24/2002 | US6497877 Plasminogen activator as an anti-inflammatory agent |
| 12/24/2002 | US6497876 Method of stimulating an immune response with activated dendritic cells |
| 12/24/2002 | US6497874 Modified filamentous phage which retains ability to bind and infect helicobacter pylori |
| 12/24/2002 | US6497872 Neural transplantation using proliferated multipotent neural stem cells and their progeny |
| 12/24/2002 | US6497871 Polypeptide having anti-viral and anti-proliferative activity |
| 12/24/2002 | US6497870 Inhibiting interferon-gamma production induced by interleukin-18 in human suffering from viral infection by administering polypeptide having specified amino acid sequence, not interleukin-1 beta-induced inflammation |
| 12/24/2002 | US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis |
| 12/24/2002 | CA2172955C Liposomal defensins |
| 12/24/2002 | CA2147863C Determination of peptide motifs on mhc molecules |